1,509 Schools In Jakarta Ready To Hold Face-to-face Learning Next Week

ILLUSTRATION/BETWEEN

JAKARTA - The DKI Jakarta Education Office said 1,509 schools are ready to hold face-to-face learning (PTM) starting Monday, September 27.

This is stated in the Decree (SK) of the Head of the DKI Jakarta Education Office Number 984 of 2021 concerning the determination of educational units that carry out Limited PTM phase II during the PPKM period.

"Determining an educational unit that will implement the second mixed PTM during the PPKM period," wrote the Head of the DKI Education Agency, Nahdiana, quoted by Antara, Saturday, September 25.

In the decree, there are 899 additional schools that will be opened starting Monday next week.

The details, as many as 809 public schools from kindergarten to high school and vocational schools, as well as 90 madrasas from RA to MA levels.

These hundreds of schools add to the 610 schools that previously held the first phase of Limited PTM since last August 30.

With this addition, a total of 1,509 schools in the capital will be opened for PTM Limited.

"The implementation of the Limited PTM Phase II during the PPKM period starts on September 27 with periodic evaluations," the letter said.

Child Vaccination

With the increasing number of schools that will hold limited PTM, vaccination for children under 12 years old is being asked by various parties to be carried out immediately.

Deputy Governor of DKI Jakarta Ahmad Riza Patria said the DKI Provincial Government is still waiting for a decision from the central government regarding vaccination of children under 12 years old. However, he hopes that children under the age of 12 can immediately be injected with the COVID-19 vaccine as protection.

Moreover, the DKI Jakarta Health Office found a cluster of COVID-19 transmission at SDN 03 Klender, East Jakarta.

"Of course this is our concern, we are happy if it is possible which vaccines are allowed for children (under 12 years old). Of course it will help all of us, so that children are not exposed to COVID-19," he said, Friday (9/24). ) night.

Previously, vaccine manufacturers Pfizer and BioNTech stated that their COVID-19 vaccine was safe for children aged 5-11 years. This vaccine is also able to form a strong immune system in children.

Pfizer is currently planning to seek permission to use vaccines for children in the United States, Europe and other countries. The company says the COVID-19 vaccine with two injections will produce an immune response in children aged 5 to 11 years in phase II/III clinical trials.

"Since July, cases of COVID-19 in children have increased by about 240 percent in the United States, so the public needs vaccinations," said Pfizer Chief Executive Albert Bourla in a statement.

The results of these clinical trials will be submitted to the United States Food and Drug Administration (FDA) and similar agencies in other countries.

Acting FDA Commissioner Janet Woodcock said she would look at the results of clinical trials before deciding whether Pfizer's vaccine was safe for children. "We will look at the clinical data and make sure that children are responding to the vaccine as expected," Woodcock said.

Meanwhile in Indonesia, Spokesperson for the COVID-19 Task Force (Satgas) Wiku Adisasmito said the use of the Pfizer vaccine was not allowed for children under 12 years of age.

This refers to the emergency use authorization (EUA) issued by the Food and Drug Supervisory Agency (BPOM). Wiku's statement was in response to the results of a phase II/III clinical trial by Pfizer-BioNTech which showed the Pfizer vaccine was safe for children aged 5-11 years.

"So far, the Indonesian government is still referring to the EUA for the Pfizer vaccine issued by the POM since July 15," said Wiku, in a press conference broadcast on the Presidential Secretariat's YouTube, Thursday, September 23.